Stay updated on Surufatinib in Biliary Tract Carcinoma: Clinical Trial

Sign up to get notified when there's something new on the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now shows a new revision tag Revision: v3.5.4 in place of the previous Revision: v3.5.3. This indicates a minor update to the study record's documentation on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-05-16T08:30:47.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    A small change in the page’s site revision/version indicator, updating it from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T16:53:55.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T13:41:33.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Revision: v3.5.0 replaces v3.4.3 on the page; no evident changes to study details or related information.
    Difference
    0.1%
    Check dated 2026-03-19T23:40:28.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3; no changes to study content are visible.
    Difference
    0.1%
    Check dated 2026-03-12T20:23:05.000Z thumbnail image
  9. Check
    114 days ago
    Change Detected
    Summary
    Revision: v3.4.2 released, replacing v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-12T02:41:09.000Z thumbnail image

Stay in the know with updates to Surufatinib in Biliary Tract Carcinoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page.